Blink-182 frontman Mark Hoppus reveals battling cancer

Mark Hoppus, the founding member, bassist and singer for pop-punk band Blink-182, announced on Wednesday that he is undergoing treatment for cancer.

The 49-year-old shared the tragic news of in a statement shared on Twitter, where he disclosed he has been undergoing chemotherapy for the past three months. “I have cancer,” he started off saying. “It sucks and I’m scared, and at the same time, I’m blessed with incredible doctors and family and friends to get me through this,” continued the musician.

Hoppus still has months of treatment sessions ahead of him but is “trying to remain hopeful and positive.” He concluded, “Can’t wait to be cancer-free and see you all at a concert in the near future. Love you all."

Following this, Hoppus’ Blink-182 band mates came out in support of the musician on social media. The band’s former singer, songwriter and guitarist Tom DeLonge said he had been aware of Hoppus’ diagnosis “for a while now” and called him “strong” conceivably for fighting his battle without the support of his fans all this time. “To add to his own words that he used today, I would also like to say that he is strong, and a super-human who is pushing through this difficult obstacle with a wide-open heart,” Delonge wrote.

Drummer Travis Barker, on the other hand, shared a sweet message for Hoppus on his Instagram Stories Wednesday night. The post featured an older photo of Barker and Hoppus embracing, with the caption “Love you @MarkHoppus.”

Hoppus’ most recent work is with Simple Creatures, a pop-punk duo consisting of him and All Time Low’s Alex Gaskarth. Blink-182 was originally formed by Hoppus, DeLonge and former drummer Scott Raynor in the early 1990s, with the trio releasing the band’s debut album Cheshire Cat in 1995. Barker replaced Rayner as drummer ahead of their sophomore breakout Enema of the State, which dropped in 1999 and shot the pop-punk icons to fame with hits like All the Small Things.

Have something to add to the story? Share it in the comments below.